A Study to Evaluate the Changes in Noninvasive Liver Fibrosis Indices and Spleen Size in Patients With Colorectal Cancer and Advanced Gastric Cancer Treated With Oxaliplatin Based Chemotherapy

Trial Profile

A Study to Evaluate the Changes in Noninvasive Liver Fibrosis Indices and Spleen Size in Patients With Colorectal Cancer and Advanced Gastric Cancer Treated With Oxaliplatin Based Chemotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2016

At a glance

  • Drugs Oxaliplatin (Primary)
  • Indications Colorectal cancer; Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top